Episode summary
Wall Street Week | Warsh’s Waiting Game, EU Merger Rules, Robotic Surgeons
Wall Street Week
· · 57 min · Guests: Jason Furman
Summary
The episode opens with the Federal Reserve’s decision to hold rates steady and Jason Furman arguing that the dissenting votes mattered most because they showed where parts of the committee want rates to go. He says inflation remains “intolerably high,” but the labor market is unusually stable, so the Fed can focus mainly on price stability. Furman also argues that tariffs and the Iran conflict have pushed prices higher, but that the bigger risk is whether those shocks spread into wages and broader price setting. He sees the bond market’s reaction, including the 30-year yield move, as a sign that investors still expect the Fed to defend its credibility.
The show then turns to Europe’s revised merger guidelines, which are meant to help the EU foster tech champions and give companies more room to argue that mergers can improve innovation, resilience, and efficiency. The guests describe the rules as more forward-looking but not a major sea change, and they suggest the deeper problem for Europe may be the weak single market rather than antitrust policy alone.
Johnson & Johnson’s robotic surgery push is presented as a late entry into a fast-growing field dominated by Intuitive. J&J says Ottava’s integrated design and room-saving setup could still make it a meaningful business, even if the company is starting behind. The final segment on think tanks, and Furman’s closing remarks on AI, frame ideas and technology as questions of institutions, incentives, and moral judgment as much as economics.
Key takeaways
- Furman says the Fed’s dissents matter more than the no-change rate decision because they signal where policy is likely headed next.
- He argues inflation is still too high, but the stronger labor market gives the Fed more room to prioritize inflation over employment.
- The European Commission’s new merger guidance is designed to reward innovation and efficiencies, but it may be more clarification than revolution.
- Johnson & Johnson says Ottava could become material toward the end of the decade despite entering robotic surgery behind Intuitive.
- Furman argues AI policy should focus on avoiding harms like bioweapons while handling job displacement through the broader tax and labor system.
Notable quotes
“-The dissents were the most important. It's very clear where a lot of members of this committee want rates to go going forward”
“Inflation is intolerably high. It's been intolerably high for 5 straight years now”
“the Fed really just needs to worry about the one side of its mandate right now, which is inflation”
“I think that's probably closer to the second, that we can't really tell the AI companies, "You can't replace jobs”
“-I don't think these guidelines will be a sea change. I think there'll be a clarification”
How the episode opens
David Westin: This is "Wall Street Week. I'm David Westin, bringing you stories of capitalism. The European Union is moving toward new merger guidelines to help it develop the sort of tech champions that drive much of U.S.
growth. Will they do the trick? Plus, Johnson & Johnson finally got approval for its new approach to robotic surgery.
Now it needs to do some catching up in a rapidly growing field. And the U.S. leads the world in think tanks.
We take a hard look at what they are and what they really accomplish. But we start with the Federal Reserve decision this week addressing persistent inflation, rising borrowing costs, and a whole lot of uncertainty. Jason Furman is professor of economics at Harvard and served as the chair of President Obama's Council of Economic Advisors.
So, Jason, we got 3 things out of the Federal Reserve this week, we got a decision not to do anything about rates. We got a statement that didn't change a whole lot from what it had before. And then we got a news conference from Chair Warsh.
Of the three, which was the most important? -The dissents were the most important. It's very clear where a lot of members of this committee want rates to go going forward.
Westin: And in the news conference, certainly Chair Warsh was asked about those dissents, why they dissented, why he disagreed with them. I'm not sure we got a clear answer to that question. Do we have a sense from him, from the way he thinks about it, why he did not join with the dissents?
-I don't think we got a clear sense from him. I think he has two, Chair Warsh has two points which I agree with him on. One is you want to look at financial conditions and there's been a lot of tightening on the long end of the curve.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- fed rate decision
- kevin warsh
- eu merger rules
- robotic surgery
- think tanks roi
Companies and tickers mentioned
- JNJ
- Johnson & Johnson
Watch the episode
Watch “Wall Street Week | Warsh’s Waiting Game, EU Merger Rules, Robotic Surgeons” on YouTube
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Wall Street Week
-
Wall Street Week | Nvidia Shakeup, Midwest Stadium Bids, Care Work Gap, India’s Wedding Economy -
What American Manufacturers Are Telling the Fed about the Economy -
Europe’s Welfare State Faces a Reckoning -
How the Blue Wave Could Reshape America’s Economy -
Inside Alaska’s Oil Paradox -
Wall Street Week | Blue Wave Economic Impacts, European Welfare Woes
Wall Street Week, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.
